Literature DB >> 8178800

Molecular basis and hematological characterization of Hb H disease in southeast Asia.

T C Liu1, S S Chiou, S F Lin, T P Chen, W P Tseng, P H Chen, J G Chang.   

Abstract

We molecularly characterized sixty-seven cases of Hb H disease by the polymerase chain reaction. The strategy depends on amplifying the alpha-thalassemia-1 (alpha-thal-1) gene by primers flanking the breakpoint and sequence differences of the 3' end of the alpha-globin gene and the nonhomologous elements I, II, and III among different types of alpha-thala-2. In the 67 cases studied, all involved alpha-thal-1 of the Southeast Asia type (SEA) in combination with deletional or nondeletional alpha-thal-2. Thirty-two cases were of the deletion form and 35 cases were of the nondeletion form. In 32 cases of the deletion form, 29 cases were rightward deletion (-alpha 3.7), and three cases were leftward deletion (-alpha 4.2). We found that all of the nondeletion forms were alpha-thal-1 of SEA type with Hb CS. After the subtyping of Hb H with -alpha 3.7, 26 out of 29 were type I deletion and 3 out of 29 were type II deletion. Comparisons of clinical data of deletion forms and the nondeletion form showed that there were earlier occurrence of anemic symptoms and a larger erythrocyte volume in the nondeletion form group (P < 0.005).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8178800     DOI: 10.1002/ajh.2830450405

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  PCR-based analysis of alpha-thalassemia in Southern Taiwan.

Authors:  Tyen-Po Chen; Ta-Chih Liu; Chao-Sung Chang; Jang-Gowth Chang; Hui-Jen Tsai; Sheng-Fung Lin
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Hemoglobin Constant Spring among Southeast Asian Populations: Haplotypic Heterogeneities and Phylogenetic Analysis.

Authors:  Wittaya Jomoui; Goonnapa Fucharoen; Kanokwan Sanchaisuriya; Van Hoa Nguyen; Supan Fucharoen
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.